Skip to main content
Equibles

Laird Norton Wetherby Trust Company, LLC

Bank

Position in RDY — Dr Reddys Laboratories Ltd

CIK 723204 Seattle, WA
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,609,328
-$164,602 QoQ
Shares Held
249,091
-8.6% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#40
of 238 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Laird Norton Wetherby Trust Company, LLC holds $8,724,768 across 9 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (41.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
This page 		249,091 $3,609,328
2 HLN
Haleon plc
 126,415 $1,179,451
3 TAK
Takeda Pharmaceutical Co Ltd
 54,386 $871,807
4 ZTS
Zoetis Inc.
 10,901 $783,345
5 NBIX
Neurocrine Biosciences Inc
 3,478 $586,181
6 TEVA
Teva Pharmaceutical Industries Ltd
 17,179 $582,024
7 UTHR
UNITED THERAPEUTICS Corp
 1,015 $549,957
8 VTRS
Viatris Inc
 19,965 $317,043

All Filings in RDY

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,609,328 249,091
2026-03-31 $3,773,930 272,486
2025-12-31 $3,702,768 263,730